Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations
Noelia Martínez-Jáñez(Hospital Universitario Ramón y Cajal), Miguel Quintela-Fandiño(Spanish National Cancer Research Centre)
Cited by 3
Related Papers
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
|Nature Communications|2019|66